**Core Concept**
Methemoglobinemia is a condition characterized by an abnormal amount of methemoglobin (metHb) in the blood, which can lead to tissue hypoxia. Local anesthetics can cause methemoglobinemia by inducing the oxidation of hemoglobin to methemoglobin.

**Why the Correct Answer is Right**
The correct answer is associated with the local anesthetic prilocaine, which is metabolized by xanthine oxidase to o-toluidine. This metabolite is a potent oxidizing agent that can convert hemoglobin to methemoglobin. The production of methemoglobin can lead to tissue hypoxia, particularly in patients with pre-existing cardiovascular disease. The severity of methemoglobinemia is dose-dependent and can be exacerbated by other factors such as smoking or concomitant use of other oxidizing agents.

**Why Each Wrong Option is Incorrect**
**Option A:** This option is incorrect because it does not specify the local anesthetic associated with methemoglobinemia. While some local anesthetics may cause methemoglobinemia, prilocaine is the most well-documented culprit.
**Option B:** This option is incorrect because it does not mention the specific mechanism by which the local anesthetic causes methemoglobinemia. While some local anesthetics may be metabolized by xanthine oxidase, not all are associated with methemoglobinemia.
**Option C:** This option is incorrect because it does not specify the local anesthetic associated with methemoglobinemia. While some local anesthetics may cause methemoglobinemia, prilocaine is the most well-documented culprit.

**Clinical Pearl / High-Yield Fact**
When using prilocaine for local anesthesia, it is essential to monitor patients for signs of methemoglobinemia, such as cyanosis, dyspnea, or tachycardia. Patients with pre-existing cardiovascular disease or those who smoke should be closely monitored for increased risk of methemoglobinemia.

**Correct Answer: A. Prilocaine**